Symbols / NDRA Stock $4.97 -0.60% ENDRA Life Sciences Inc.
NDRA (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source comprising radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Ratings
Current target
$4.97
Low
$27.00
High
$27.00
Mean
$27.00
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-12-08 | main | Ascendiant Capital | Buy → Buy | $30 |
| 2025-09-22 | main | Ascendiant Capital | Buy → Buy | $38 |
| 2025-05-30 | main | Ascendiant Capital | Buy → Buy | $46 |
| 2025-04-21 | main | Ascendiant Capital | Buy → Buy | $50 |
| 2024-06-07 | main | Ascendiant Capital | Buy → Buy | $8 |
| 2023-03-31 | reit | HC Wainwright & Co. | — → Buy | $9 |
- Equity shortfall puts ENDRA Life Sciences (NASDAQ: NDRA) at renewed Nasdaq delisting risk - Stock Titan ue, 21 Apr 2026 12
- ENDRA Life Sciences Faces Renewed Nasdaq Listing Compliance Risk - TipRanks ue, 21 Apr 2026 12
- ENDRA Life (NDRA) Stock: Price Action (Declines) 2026-04-20 - Downside Risk - Cổng thông tin điện tử Tỉnh Sơn La ue, 21 Apr 2026 02
- Press Releases about Hyperliquid Strategies Inc - Common Stock (Nasdaq:PURR) - FinancialContent Sun, 26 Apr 2026 17
- ENDRA Life (NDRA) Stock Chart | Q4 2025: Earnings Fall Short - Free Cash Margin - Cổng thông tin điện tử tỉnh Tây Ninh Wed, 22 Apr 2026 21
- ENDRA Life Sciences (NDRA) price target decreased by 10.00% to 27.54 - MSN Fri, 24 Apr 2026 03
- Small-Cap Medical Stocks: ATAI, CMPS, NDRA, PBM in Focus as U.S. Policy Accelerates Psychedelic Research - marketscreener.com ue, 21 Apr 2026 08
- ENDRA Life Sciences stock falls after liver device study results - Investing.com hu, 04 Dec 2025 08
- ENDRA LIFE SCIENCES Earnings Preview: Recent $NDRA Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative Mon, 18 Aug 2025 07
- ENDRA puts sale, merger and asset options on the table - Stock Titan Wed, 25 Mar 2026 07
- Press Releases about Battalion Oil Corporation Common Stock (NYSE:BATL) - FinancialContent Sat, 25 Apr 2026 22
- Is ENDRA Life (NDRA) Stock Near Resistance | Price at $5.10, Down 4.49% - Trending Entry Points - Cổng thông tin điện tử Tỉnh Sơn La Wed, 08 Apr 2026 07
- ENDRA Life Sciences stock soars after securing $4.9M for crypto strategy - Investing.com Mon, 13 Oct 2025 07
- Device targets MRI-like liver fat tests for 2B MASLD patients - Stock Titan hu, 26 Feb 2026 08
- ENDRA Life Sciences explores strategic alternatives - Investing.com Wed, 25 Mar 2026 07
Insider Transactions
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Gross Profit |
|
—
|
—
|
—
|
—
|
| Operating Expense |
|
5.76
-46.72%
|
10.82
+2.82%
|
10.52
-20.04%
|
13.16
|
| Research And Development |
|
1.85
-42.01%
|
3.19
-36.24%
|
5.00
-23.66%
|
6.55
|
| Selling General And Administration |
|
3.91
-48.69%
|
7.63
+38.24%
|
5.52
-16.45%
|
6.60
|
| Selling And Marketing Expense |
|
0.19
-66.82%
|
0.57
-30.41%
|
0.82
-42.58%
|
1.43
|
| General And Administrative Expense |
|
3.72
-47.23%
|
7.06
+50.24%
|
4.70
-9.23%
|
5.17
|
| Other Gand A |
|
3.72
-47.23%
|
7.06
+50.24%
|
4.70
-9.23%
|
5.17
|
| Total Expenses |
|
5.76
-46.72%
|
10.82
+2.82%
|
10.52
-20.04%
|
13.16
|
| Operating Income |
|
-5.76
+46.72%
|
-10.82
-2.82%
|
-10.52
+20.04%
|
-13.16
|
| Total Operating Income As Reported |
|
-5.76
+46.72%
|
-10.82
-2.82%
|
-10.52
+20.04%
|
-13.16
|
| EBITDA |
|
-5.61
+47.17%
|
-10.61
-3.57%
|
-10.25
+20.72%
|
-12.92
|
| Normalized EBITDA |
|
-4.27
+56.53%
|
-9.81
+4.23%
|
-10.25
+20.72%
|
-12.92
|
| Reconciled Depreciation |
|
0.16
-23.71%
|
0.21
-25.15%
|
0.28
+17.58%
|
0.23
|
| EBIT |
|
-5.76
+46.72%
|
-10.82
-2.82%
|
-10.52
+20.04%
|
-13.16
|
| Total Unusual Items |
|
-1.34
-67.73%
|
-0.80
|
—
|
0.00
|
| Total Unusual Items Excluding Goodwill |
|
-1.34
-67.73%
|
-0.80
|
—
|
0.00
|
| Special Income Charges |
|
—
|
—
|
—
|
0.00
|
| Other Special Charges |
|
—
|
—
|
—
|
—
|
| Net Income |
|
-7.03
+38.93%
|
-11.51
-14.39%
|
-10.06
+23.67%
|
-13.18
|
| Pretax Income |
|
-7.03
+38.93%
|
-11.51
-14.39%
|
-10.06
+23.67%
|
-13.18
|
| Net Non Operating Interest Income Expense |
|
—
|
-7.32
|
—
|
—
|
| Interest Expense Non Operating |
|
—
|
—
|
—
|
—
|
| Net Interest Income |
|
—
|
-7.32
|
—
|
—
|
| Interest Expense |
|
—
|
—
|
—
|
—
|
| Other Income Expense |
|
-1.26
-83.02%
|
-0.69
-250.02%
|
0.46
+2238.51%
|
-0.02
|
| Other Non Operating Income Expenses |
|
0.08
-29.63%
|
0.11
-76.44%
|
0.46
+2238.51%
|
-0.02
|
| Gain On Sale Of Security |
|
-1.34
-67.73%
|
-0.80
|
—
|
—
|
| Tax Provision |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-7.03
+38.93%
|
-11.51
-14.39%
|
-10.06
+23.67%
|
-13.18
|
| Net Income From Continuing Operation Net Minority Interest |
|
-7.03
+38.93%
|
-11.51
-14.39%
|
-10.06
+23.67%
|
-13.18
|
| Net Income From Continuing And Discontinued Operation |
|
-7.03
+38.93%
|
-11.51
-14.39%
|
-10.06
+23.67%
|
-13.18
|
| Net Income Continuous Operations |
|
-7.03
+38.93%
|
-11.51
-14.39%
|
-10.06
+23.67%
|
-13.18
|
| Normalized Income |
|
-5.69
+46.90%
|
-10.71
-6.45%
|
-10.06
+23.67%
|
-13.18
|
| Net Income Common Stockholders |
|
-7.03
+38.93%
|
-11.51
-14.39%
|
-10.06
+23.67%
|
-13.18
|
| Otherunder Preferred Stock Dividend |
|
—
|
—
|
—
|
0.00
|
| Diluted EPS |
|
-8.93
+84.32%
|
-56.94
+97.94%
|
-2,766.85
+65.33%
|
-7,980.00
|
| Basic EPS |
|
-8.93
+84.32%
|
-56.94
+97.94%
|
-2,766.85
+65.33%
|
-7,980.00
|
| Basic Average Shares |
|
0.79
+289.41%
|
0.20
+5458.47%
|
0.00
+120.10%
|
0.00
|
| Diluted Average Shares |
|
0.79
+289.41%
|
0.20
+5458.47%
|
0.00
+120.10%
|
0.00
|
| Diluted NI Availto Com Stockholders |
|
-7.03
+38.93%
|
-11.51
-14.39%
|
-10.06
+23.67%
|
-13.18
|
| Total Other Finance Cost |
|
—
|
7.32
|
—
|
—
|
| Line Item | Trend | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Total Assets |
|
9.27
|
—
|
| Current Assets |
|
5.38
|
—
|
| Cash Cash Equivalents And Short Term Investments |
|
4.89
|
—
|
| Cash And Cash Equivalents |
|
4.89
|
—
|
| Cash Financial |
|
4.89
|
—
|
| Inventory |
|
2.64
+105.88%
|
1.28
|
| Raw Materials |
|
—
|
1.28
|
| Prepaid Assets |
|
0.49
|
—
|
| Total Non Current Assets |
|
3.89
|
—
|
| Net PPE |
|
0.74
|
—
|
| Gross PPE |
|
1.39
|
—
|
| Accumulated Depreciation |
|
-0.64
|
—
|
| Properties |
|
0.74
|
—
|
| Construction In Progress |
|
0.14
|
—
|
| Other Properties |
|
0.51
|
—
|
| Non Current Prepaid Assets |
|
0.50
|
—
|
| Other Non Current Assets |
|
2.65
|
—
|
| Total Liabilities Net Minority Interest |
|
2.07
|
—
|
| Current Liabilities |
|
1.70
|
—
|
| Payables And Accrued Expenses |
|
0.83
|
—
|
| Payables |
|
0.61
|
—
|
| Accounts Payable |
|
0.61
|
—
|
| Current Accrued Expenses |
|
0.22
|
—
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
0.69
|
—
|
| Current Debt And Capital Lease Obligation |
|
0.18
|
—
|
| Current Debt |
|
0.03
|
—
|
| Other Current Borrowings |
|
0.03
|
—
|
| Current Capital Lease Obligation |
|
0.15
|
—
|
| Total Non Current Liabilities Net Minority Interest |
|
0.37
|
—
|
| Long Term Debt And Capital Lease Obligation |
|
0.37
|
—
|
| Long Term Debt |
|
—
|
0.03
|
| Long Term Capital Lease Obligation |
|
0.37
|
—
|
| Stockholders Equity |
|
7.20
|
—
|
| Common Stock Equity |
|
7.20
|
—
|
| Capital Stock |
|
0.00
|
—
|
| Common Stock |
|
0.00
|
—
|
| Preferred Stock |
|
0.00
|
—
|
| Share Issued |
|
0.00
|
—
|
| Ordinary Shares Number |
|
0.00
|
—
|
| Additional Paid In Capital |
|
89.07
|
—
|
| Retained Earnings |
|
-81.87
|
—
|
| Total Equity Gross Minority Interest |
|
7.20
|
—
|
| Total Capitalization |
|
7.20
|
—
|
| Working Capital |
|
3.68
|
—
|
| Invested Capital |
|
7.23
|
—
|
| Total Debt |
|
0.55
|
—
|
| Capital Lease Obligations |
|
0.52
|
—
|
| Net Tangible Assets |
|
7.20
|
—
|
| Tangible Book Value |
|
7.20
|
—
|
| Derivative Product Liabilities |
|
—
|
—
|
| Other Equity Interest |
|
0.01
-56.19%
|
0.01
|
| Preferred Shares Number |
|
0.00
+0.00%
|
0.00
|
| Preferred Stock Equity |
|
0.00
+0.00%
|
0.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-5.18
+29.97%
|
-7.40
+22.50%
|
-9.55
+25.22%
|
-12.77
|
| Cash Flow From Continuing Operating Activities |
|
-5.18
+29.97%
|
-7.40
+22.50%
|
-9.55
+25.22%
|
-12.77
|
| Net Income From Continuing Operations |
|
-7.03
+38.93%
|
-11.51
-14.39%
|
-10.06
+23.67%
|
-13.18
|
| Depreciation Amortization Depletion |
|
0.16
-23.71%
|
0.21
-25.15%
|
0.28
+17.58%
|
0.23
|
| Depreciation |
|
0.16
-23.71%
|
0.21
-25.15%
|
0.28
+17.58%
|
0.23
|
| Depreciation And Amortization |
|
0.16
-23.71%
|
0.21
-25.15%
|
0.28
+17.58%
|
0.23
|
| Other Non Cash Items |
|
-0.01
-512000.00%
|
-0.00
|
—
|
—
|
| Stock Based Compensation |
|
0.33
-42.40%
|
0.57
-42.60%
|
1.00
-16.95%
|
1.20
|
| Provisionand Write Offof Assets |
|
0.00
-100.00%
|
2.39
+1629.24%
|
0.14
|
0.00
|
| Asset Impairment Charge |
|
0.00
-100.00%
|
0.01
-64.58%
|
0.02
+1687.78%
|
0.00
|
| Operating Gains Losses |
|
0.35
-56.77%
|
0.80
|
—
|
—
|
| Gain Loss On Investment Securities |
|
0.35
-56.77%
|
0.80
|
—
|
—
|
| Unrealized Gain Loss On Investment Securities |
|
1.00
|
0.00
|
—
|
—
|
| Change In Working Capital |
|
0.02
-83.13%
|
0.13
+114.52%
|
-0.92
+9.99%
|
-1.03
|
| Change In Inventory |
|
0.00
-100.00%
|
0.24
+302.88%
|
-0.12
+91.46%
|
-1.36
|
| Change In Prepaid Assets |
|
-0.00
-100.55%
|
0.26
+52.91%
|
0.17
-52.87%
|
0.36
|
| Change In Payables And Accrued Expense |
|
0.11
+156.97%
|
-0.20
+75.81%
|
-0.82
-836.96%
|
0.11
|
| Change In Other Current Assets |
|
—
|
—
|
—
|
—
|
| Change In Other Current Liabilities |
|
-0.09
+43.76%
|
-0.16
-4.25%
|
-0.15
-15.04%
|
-0.13
|
| Investing Cash Flow |
|
-3.02
-23479.87%
|
-0.01
+48.24%
|
-0.02
+87.80%
|
-0.20
|
| Cash Flow From Continuing Investing Activities |
|
-3.02
-23479.87%
|
-0.01
+48.24%
|
-0.02
+87.80%
|
-0.20
|
| Net PPE Purchase And Sale |
|
-0.02
-35.04%
|
-0.01
+48.24%
|
-0.02
+87.80%
|
-0.20
|
| Purchase Of PPE |
|
-0.02
-8.00%
|
-0.02
+52.78%
|
-0.03
+83.27%
|
-0.20
|
| Sale Of PPE |
|
0.00
-100.00%
|
0.00
-65.03%
|
0.01
|
0.00
|
| Capital Expenditure |
|
-3.02
-18758.00%
|
-0.02
+52.78%
|
-0.03
+83.27%
|
-0.20
|
| Net Intangibles Purchase And Sale |
|
-3.00
|
0.00
|
—
|
—
|
| Purchase Of Intangibles |
|
-3.00
|
0.00
|
—
|
—
|
| Financing Cash Flow |
|
5.73
-26.59%
|
7.81
+3.87%
|
7.52
-10.49%
|
8.40
|
| Cash Flow From Continuing Financing Activities |
|
5.73
-26.59%
|
7.81
+3.87%
|
7.52
-10.49%
|
8.40
|
| Net Issuance Payments Of Debt |
|
0.00
+100.00%
|
-0.03
|
—
|
—
|
| Issuance Of Debt |
|
—
|
—
|
—
|
—
|
| Repayment Of Debt |
|
0.00
+100.00%
|
-0.03
|
—
|
—
|
| Long Term Debt Issuance |
|
—
|
—
|
—
|
—
|
| Long Term Debt Payments |
|
0.00
+100.00%
|
-0.03
|
—
|
—
|
| Net Long Term Debt Issuance |
|
0.00
+100.00%
|
-0.03
|
—
|
—
|
| Short Term Debt Payments |
|
—
|
-0.03
|
—
|
—
|
| Net Short Term Debt Issuance |
|
—
|
-0.03
|
—
|
—
|
| Net Common Stock Issuance |
|
5.73
-12.03%
|
6.52
+0.52%
|
6.48
-22.81%
|
8.40
|
| Proceeds From Stock Option Exercised |
|
0.00
-100.00%
|
1.32
+27.60%
|
1.03
|
0.00
|
| Net Other Financing Charges |
|
—
|
0.00
|
—
|
—
|
| Changes In Cash |
|
-2.47
-723.68%
|
0.40
+119.25%
|
-2.06
+55.05%
|
-4.57
|
| Beginning Cash Position |
|
3.23
+13.96%
|
2.83
-42.04%
|
4.89
-48.33%
|
9.46
|
| End Cash Position |
|
0.76
-76.39%
|
3.23
+13.96%
|
2.83
-42.04%
|
4.89
|
| Free Cash Flow |
|
-8.20
-10.56%
|
-7.42
+22.60%
|
-9.58
+26.13%
|
-12.97
|
| Interest Paid Supplemental Data |
|
0.06
+75.02%
|
0.03
-29.07%
|
0.04
-23.90%
|
0.06
|
| Income Tax Paid Supplemental Data |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Common Stock Issuance |
|
5.73
-12.03%
|
6.52
+0.52%
|
6.48
-22.81%
|
8.40
|
| Issuance Of Capital Stock |
|
5.73
-12.03%
|
6.52
+0.52%
|
6.48
-22.81%
|
8.40
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-04-21 View
- 10-K2026-03-31 View
- 8-K2026-03-31 View
- 8-K2026-03-25 View
- 42026-03-04 View
- 42026-03-04 View
- 42026-01-23 View
- 42026-01-23 View
- 42026-01-23 View
- 42026-01-23 View
- 42026-01-23 View
- 8-K2025-12-15 View
- 8-K2025-11-28 View
- 8-K2025-11-14 View
- 10-Q2025-11-14 View
- 8-K2025-10-30 View
- 8-K2025-10-23 View
- 42025-10-15 View
- 8-K2025-10-15 View
- 10-Q2025-08-14 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|